Portugal, May 1 -- Portugal based ROCHE FARMACEUTICA QUIMICA, LDA. has secured contract from Unidade Local De Saude Do Alentejo Central, E.P.E for Acquisition Of The Medication - Ocrelizumab. The value of the contract is worth 35909880 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....